| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
2e-07 |
| mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
Vandetanib |
CCLE |
pan-cancer |
AAC |
-0.24 |
3e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-06 |
| mRNA |
ciclopirox |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-06 |
| mRNA |
BRD8899 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
9e-06 |
| mRNA |
BIX-01294 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-05 |
| mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |
| mRNA |
Erlotinib |
CCLE |
pan-cancer |
AAC |
-0.21 |
2e-05 |
| mRNA |
BRD-K52037352 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-05 |